Cleared Traditional

K943436 - URINE REAGENT STRIPS-8 PARAMETERS (FDA 510(k) Clearance)

Class I Chemistry device.

K943436 · Teco Diagnostics · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1995
Decision
280d
Days
Class 1
Risk

K943436 is an FDA 510(k) clearance for the URINE REAGENT STRIPS-8 PARAMETERS. Classified as Azo-dyes, Colorimetric, Bilirubin & Its Conjugates (urinary, Non-quant.) (product code JJB), Class I - General Controls.

Submitted by Teco Diagnostics (Placentia, US). The FDA issued a Cleared decision on April 24, 1995 after a review of 280 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1115 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Teco Diagnostics devices

Submission Details

510(k) Number K943436 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 1994
Decision Date April 24, 1995
Days to Decision 280 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
192d slower than avg
Panel avg: 88d · This submission: 280d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJB Azo-dyes, Colorimetric, Bilirubin & Its Conjugates (urinary, Non-quant.)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1115
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.